A meta-analysis of re-treatment for intravenous immunoglobulin-resistant Kawasaki disease

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial

(2012) Tohru Kobayashi et al.   LANCET

Steroid Pulse Therapy for Children With Intravenous Immunoglobulin Therapy–Resistant Kawasaki Disease: A Prospective Study

(2012) Masayuki Teraguchi et al.   PEDIATRIC CARDIOLOGY

A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease

(2011) Bo-hui Zhu et al.   EUROPEAN JOURNAL OF PEDIATRICS

ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease

(2011) Y Onouchi et al.   PHARMACOGENOMICS JOURNAL

Parameters to Guide Retreatment After Initial Intravenous Immunoglobulin Therapy in Kawasaki Disease

(2011) Hyun Kwon Kim et al.   Korean Circulation Journal

Corticosteroid administration for patients with coronary artery aneurysms after Kawasaki disease may be associated with impaired regression

(2010) Kyle Millar et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin

(2009) Caroline Galeotti et al.   AUTOIMMUNITY REVIEWS

Long-Term Prognosis of Patients with Kawasaki Disease: At Risk for Future Atherosclerosis?

(2009) Ryuji Fukazawa et al.   JOURNAL OF NIPPON MEDICAL SCHOOL

Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin

(2008) Masaru Miura et al.   EUROPEAN JOURNAL OF PEDIATRICS

The strategy of immune globulin resistant Kawasaki disease: A comparative study of additional immune globulin and steroid pulse therapy

(2008) Shohei Ogata et al.   Journal of Cardiology